Article in Advanced nanobiomed research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
10 authors.
Jay V ShahDepartment of Biomedical Engineering Rutgers University 599 Taylor Rd Piscataway NJ 08854 USA.
Jake N SiebertDepartment of Biomedical Engineering Rutgers University 599 Taylor Rd Piscataway NJ 08854 USA.
Xinyu ZhaoEngineering Product Development Singapore University of Technology and Design 8 Somapah Rd Tampines Singapore 487372 Singapore.
Shuqing HeEngineering Product Development Singapore University of Technology and Design 8 Somapah Rd Tampines Singapore 487372 Singapore.
Richard E RimanDepartment of Materials Science and Engineering Rutgers University 607 Taylor Rd Piscataway NJ 08854 USA.
Mei Chee TanEngineering Product Development Singapore University of Technology and Design 8 Somapah Rd Tampines Singapore 487372 Singapore.
Mark C PierceDepartment of Biomedical Engineering Rutgers University 599 Taylor Rd Piscataway NJ 08854 USA.
Edmund C LattimeRutgers Cancer Institute of New Jersey 195 Little Albany St New Brunswick NJ 08901 USA.
Vidya GanapathyDepartment of Biomedical Engineering Rutgers University 599 Taylor Rd Piscataway NJ 08854 USA.
Prabhas V MogheDepartment of Biomedical Engineering Rutgers University 599 Taylor Rd Piscataway NJ 08854 USA.ORCID 0000-0002-2091-5879
Funding
TRANSCRIPTIONAL PROFILINGP30CA072720 · NCI · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI Tracie Saunders · 1997 to 2026
$94.5M
Translational Research Support CoreP30ES005022 · NIEHS · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI PANOS G. GEORGOPOULOS · 1988 to 2026
$47.4M
Rare earth nanoprobes for optical imaging and disease tracking (C3i)R01EB018378 · NIBIB · RUTGERS, THE STATE UNIV OF N.J. · PI GANAPATHY, VIDYA, MOGHE, PRABHAS V · 2014 to 2022
$4.8M
Rutgers Optimizes Innovation (ROI) ProgramU01HL150852 · NHLBI · RUTGERS BIOMEDICAL/HEALTH SCIENCES-RBHS · PI LIBUTTI, STEVEN K., PANETTIERI, REYNOLD ALEXANDER · 2019 to 2022
$4.4M
Rutgers Biotechnology Training ProgramT32GM135141 · NIGMS · RUTGERS, THE STATE UNIV OF N.J. · PI ANN M. STOCK, Martin L Yarmush · 2020 to 2026
$3.5M
Beckman Coulter MoFlo Astrios EQ Cell SorterS10OD026876 · OD · RUTGERS, THE STATE UNIV OF N.J. · PI LASKIN, DEBRA L · 2019 to 2019
Checkpoint immunotherapy has made great strides in the treatment of solid tumors, but many patients do not respond to immune checkpoint inhibitors. Identification of tumor-infiltrating cytotoxic T cells (CTLs) has the potential to stratify patients and monitor immunotherapy responses. In this study, the design of cluster of differentiation (CD8
Indexed as
cytotoxic T cellsimmune cell targetingimmunosurveillancenanotechnologiesrare-earth probesshortwave infrared imaging
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Shortwave-Infrared-Emitting Nanoprobes for CD8 Targeting and In Vivo Imaging of Cytotoxic T Cells in Breast Cancer. · full record | OpenQuestion